News
Sunday Trust on MSN1d
Sickle Cell Disease: A Deep Dive Into Nigeria's Silent Health CrisisAs the global community commemorates World Sickle Cell Day today, the spotlight turns to Nigeria-a nation bearing one of the heaviest burdens of Sickle Cell Disease (SCD) worldwide.With over 150,000 ...
4d
Cebu Daily News on MSNSickle cell disease: What you need to know about SCDAlthough sickle cell disease (SCD) is not as widespread in the Philippines compared to other populations, it is still worth ...
As World Blood Donor Day nears, health experts stress the crucial need for Black donors to help patients with sickle cell ...
Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease
Orphan Drug Designation is awarded to therapies intended to treat rare diseases that affect fewer than 200,000 people in the ...
Objective: To determine the serum levels of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea in outpatient's setting. Methods: Of the 65 patients with ...
Patients—often referred to as sickle cell warriors—face numerous health complications, including stroke, acute chest syndrome, and chronic organ damage, that lead to a significantly reduced ...
With an estimated four million Nigerians affected by sickle cell disease, experts have called on the federal government to invest in the local production of gene therapy treatments. The appeal was ...
With an estimated four million Nigerians living with sickle cell disease (SCD), health experts are advocating the adoption of gene therapy as a curative treatment option for patients in the country.
The Federal Government has commenced the expansion of sickle cell screening and management services across six designated centres of care in the country. Advertisement … Continue reading FG ...
Mtatiro SN, Singh T, Rooks H, et al. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania. PLoS One 2014;9(11):e111464-e111464. Crossref ...
CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results